Last reviewed · How we verify
lidocaine+adjunct tramadol — Competitive Intelligence Brief
phase 3
Local anesthetic, weak opioid agonist
Voltage-gated sodium channels, mu-opioid receptor, serotonin transporter, norepinephrine transporter
Pain management
Small molecule
Live · refreshed every 30 min
Target snapshot
lidocaine+adjunct tramadol (lidocaine+adjunct tramadol) — Bagcilar Training and Research Hospital. Lidocaine is a local anesthetic that blocks sodium channels to prevent nerve impulses, while tramadol is a weak opioid agonist that also inhibits serotonin and norepinephrine reuptake.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| lidocaine+adjunct tramadol TARGET | lidocaine+adjunct tramadol | Bagcilar Training and Research Hospital | phase 3 | Local anesthetic, weak opioid agonist | Voltage-gated sodium channels, mu-opioid receptor, serotonin transporter, norepinephrine transporter |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Local anesthetic, weak opioid agonist class)
- Bagcilar Training and Research Hospital · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- lidocaine+adjunct tramadol CI watch — RSS
- lidocaine+adjunct tramadol CI watch — Atom
- lidocaine+adjunct tramadol CI watch — JSON
- lidocaine+adjunct tramadol alone — RSS
- Whole Local anesthetic, weak opioid agonist class — RSS
Cite this brief
Drug Landscape (2026). lidocaine+adjunct tramadol — Competitive Intelligence Brief. https://druglandscape.com/ci/lidocaine-adjunct-tramadol. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab